Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Majestic Corp nears U.S. OTCQB listing; Genflow sees positive results in dog ageing trial.

flag Majestic Corporation Plc is close to gaining approval to list on the U.S. OTCQB Market, which would improve access for American investors and support its global expansion in sustainable recycling. flag Meanwhile, Genflow Biosciences reported a safety milestone in its dog ageing trial using a human-derived gene therapy, with no adverse effects observed after the second dose in elderly beagles. flag The trial, set to end in January 2026, aims to assess the therapy’s potential to slow ageing through enhanced cellular repair. flag In other developments, SoftBank is seeking a $5 billion loan using Arm Holdings shares as collateral to boost investments in OpenAI, while Discord investigates a data breach affecting up to 70,000 users via a compromised third-party vendor. flag The FTSE 100 declined as gold prices eased.

8 Articles